Filing Details

Accession Number:
0001209191-10-054125
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-11-10 11:24:22
Reporting Period:
2010-11-08
Filing Date:
2010-11-10
Accepted Time:
2010-11-10 11:24:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
861838 Idera Pharmaceuticals Inc. IDRA Biological Products, (No Disgnostic Substances) (2836) 043072298
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1193366 El Youssef Zein C/O Idera Pharmaceuticals, Inc.
167 Sidney Street
Cambridge MA 02139
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-11-08 19,000 $2.76 516,140 No 4 P Direct
Common Stock Acquisiton 2010-11-09 10,000 $2.79 526,140 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. Represents the weighted average purchase price for shares purchased in multiple transactions. Purchase prices ranged from $2.73 to $2.80, inclusive. Upon request of the staff of the Securities and Exchange Commission, the issuer or a security holder of such issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4.
  2. Represents the weighted average purchase price for shares purchased in multiple transactions. Purchase prices ranged from $2.75 to $2.80, inclusive.